Immune system

Multiple sclerosis drug recalled over unacceptable 'variability'

A manufacturer has recalled a medicine used to treat multiple sclerosis (MS) “as a precautionary measure”, the pharmacy negotiator has announced.

Green Party pledges to make PrEP available in pharmacies and online

The Green Party has revealed plans to inject billions of pounds into primary care and “end new cases" of HIV by 2030. 

Empowering pharmacy: Leading the charge against antimicrobial resistance

This World Antimicrobial Awareness Week, Nonyelum Anigbo talks about the role of community pharmacy in combatting increased antimicrobial resistance (AMR)

HIV: Government ‘exploring’ making PrEP available in pharmacies

A “roadmap” considering expanding the provision of HIV medication pre-exposure prophylaxis (PrEP) to “a variety of settings” will be available by the end of the year, pharmacy minister Neil O’Brien has said.  

RPS: Make HIV drug PrEP available from community pharmacies

The government should widen access to pre-exposure prophylaxis (PrEP) by making it available in community pharmacies “as soon as possible”, the Royal Pharmaceutical Society (RPS) has said. 

Pharmacy teams eligible for COVID booster jabs, as NHS readies for programme to go live next week

The JCVI has recommended that those who received their first dose of COVID-19 vaccine during phase 1 of the vaccination programme “should be offered” a third top-up dose.

MP and NPA urge NHS to allow pharmacy provision of HIV drug PrEP

The vice-chair for HIV and AIDS on the all party pharmacy group and the NPA chief executive have urged NHSE&I to allow community pharmacies to provide PrEP to patients.

How will gluten-free restrictions affect pharmacies and patients?

C+D asks three contractors what impact the prescribing restrictions on gluten-free products will have on patients with coeliac disease, and on their businesses

Understanding HIV treatments and interactions

Understanding HIV treatments and interactions

LPC: Scrapping gluten-free foods won't impact our 'affluent' patients

The decision to scrap funding for gluten-free foods will not impact patients in the "relatively affluent" Berkshire West area, a local pharmaceutical committee (LPC) has claimed.